Stopping Anemia Drug May Be Wiser Than Reducing Dose to Normalize Hemoglobin Levels

Published July 24, 2010

Stopping Anemia Drug May Be Wiser Than Reducing Dose To Normalize Hemoglobin Levels
Discontinuing the anemia drug epoetin may be more effective than reducing the dose for normalizing potentially dangerous high hemoglobin levels in hemodialysis patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The results provide useful information about the balance required between administering epoetin and …
Read more on Medical News Today

Breast cancer drug ‘still safe’ for Aussie women
A breast cancer treatment drug which may be banned in the US is still safe for use in Australia, its manufacturer says.
Read more on ABC via Yahoo!7 News